Oncology
A safer cancer journey for your patient
As clinicians, it is in your nature to provide the best possible care to patients receiving cancer treatment through vascular access devices (VADs). While VADs are an essential part of oncology care, they are often associated with risks like catheter related bloodstream infections (CRBSIs). This can lead to other complications, cause discomfort, delay treatment, and increase hospital stays for patients who are already facing so much.
When your oncology patients count on you, you can rely on us to help make their treatment journey a little easier and safer. We can enable you with evidence-based solutions to help reduce the risk of infection, dislodgement, skin damage, and other complications.
What you can expect from our oncology solutions
Clinically proven to reduce CRBSI1
Reduces the risk of CRBSI and vascular catheter colonisation.
Antimicrobial protection
I.V. dressings with chlorhexidine gluconate (CHG) provide immediate and continuous antimicrobial protection for up to 7 days, if not removed.
Reliable catheter securement
Stabilise catheters and minimise movement and dislodgement.
Focus on patient comfort
Provides long-lasting protection around vascular access sites, skin-friendly and highly breathable.
Visibility
Offers a clear view of I.V. sites to help facilitate continuous monitoring for early signs of complications.
Explore our range of oncology solutions
Discover a comprehensive range of reliable securement solutions that help prevent complications, maintain quality care, and enhance patient satisfaction.
Product resources and evidence
Support resources
References:
- Timsit, Jean-François, Olivier Mimoz, Bruno Mourvillier, Bertrand Souweine, Maïté Garrouste-Orgeas, Serge Alfandari, Gaétan Plantefeve et al. "Randomized controlled trial of chlorhexidine dressing and highly adhesive dressing for preventing catheter-related infections in critically ill adults." American journal of respiratory and critical care medicine 186, no. 12 (2012): 1272-1278.